Herdegen T[au] - Search Results

Year	Number of Results
1990	1
1991	6
1992	5
1993	13
1994	9
1995	9
1996	6
1997	9
1998	14
1999	6
2000	6
2001	6
2002	5
2003	9
2004	7
2005	8
2006	8
2007	6
2008	8
2009	8
2010	8
2011	7
2012	7
2013	5
2014	7
2015	3
2016	2
2017	4
2018	3
2019	2
2020	2
2021	4
2022	1
2023	2
2024	0

1

Drug Interactions of Tetrahydrocannabinol and Cannabidiol in Cannabinoid Drugs.

Herdegen T, Cascorbi I. Herdegen T, et al. Dtsch Arztebl Int. 2023 Dec 8;120(49):833-840. doi: 10.3238/arztebl.m2023.0223. Dtsch Arztebl Int. 2023. PMID: 37874128 Free PMC article. Review.

2

We should not avoid diclofenac in the treatment of spondyloarthritis.

Zingler G, Herdegen T. Zingler G, et al. Among authors: herdegen t. Ann Transl Med. 2018 Nov;6(Suppl 1):S36. doi: 10.21037/atm.2018.09.42. Ann Transl Med. 2018. PMID: 30613611 Free PMC article. No abstract available.

3

Cardioprotective Effect of NSAIDs.

Herdegen T, Zingler G. Herdegen T, et al. Dtsch Arztebl Int. 2017 Aug 21;114(33-34):559. doi: 10.3238/arztebl.2017.0559b. Dtsch Arztebl Int. 2017. PMID: 28855049 Free PMC article. No abstract available.

4

PPAR-gamma: therapeutic target for ischemic stroke.

Culman J, Zhao Y, Gohlke P, Herdegen T. Culman J, et al. Among authors: herdegen t. Trends Pharmacol Sci. 2007 May;28(5):244-9. doi: 10.1016/j.tips.2007.03.004. Epub 2007 Apr 9. Trends Pharmacol Sci. 2007. PMID: 17416424 Review.

5

Angiotensin peptides and inducible transcription factors.

Blume A, Herdegen T, Unger T. Blume A, et al. Among authors: herdegen t. J Mol Med (Berl). 1999 Mar;77(3):339-57. doi: 10.1007/s001090050360. J Mol Med (Berl). 1999. PMID: 10090597 Review.

6

Specific activities of individual c-Jun N-terminal kinases in the brain.

Haeusgen W, Boehm R, Zhao Y, Herdegen T, Waetzig V. Haeusgen W, et al. Among authors: herdegen t. Neuroscience. 2009 Jul 21;161(4):951-9. doi: 10.1016/j.neuroscience.2009.04.014. Epub 2009 Apr 11. Neuroscience. 2009. PMID: 19364525 Review.

7

Cardiovascular adverse events by non-steroidal anti-inflammatory drugs: when the benefits outweigh the risks.

Zingler G, Hermann B, Fischer T, Herdegen T. Zingler G, et al. Among authors: herdegen t. Expert Rev Clin Pharmacol. 2016 Nov;9(11):1479-1492. doi: 10.1080/17512433.2016.1230495. Epub 2016 Sep 8. Expert Rev Clin Pharmacol. 2016. PMID: 27575590 Review.

8

The bottleneck of JNK signaling: molecular and functional characteristics of MKK4 and MKK7.

Haeusgen W, Herdegen T, Waetzig V. Haeusgen W, et al. Among authors: herdegen t. Eur J Cell Biol. 2011 Jun-Jul;90(6-7):536-44. doi: 10.1016/j.ejcb.2010.11.008. Epub 2011 Feb 18. Eur J Cell Biol. 2011. PMID: 21333379 Review.

9

c-Jun N-terminal kinases (JNKs) and the cytoskeleton--functions beyond neurodegeneration.

Gelderblom M, Eminel S, Herdegen T, Waetzig V. Gelderblom M, et al. Among authors: herdegen t. Int J Dev Neurosci. 2004 Nov;22(7):559-64. doi: 10.1016/j.ijdevneu.2004.07.014. Int J Dev Neurosci. 2004. PMID: 15465286 Review.

10

Retinoic acid-induced survival effects in SH-SY5Y neuroblastoma cells.

Waetzig V, Haeusgen W, Andres C, Frehse S, Reinecke K, Bruckmueller H, Boehm R, Herdegen T, Cascorbi I. Waetzig V, et al. Among authors: herdegen t. J Cell Biochem. 2019 Apr;120(4):5974-5986. doi: 10.1002/jcb.27885. Epub 2018 Oct 15. J Cell Biochem. 2019. PMID: 30320919

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

192 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

192 results

Results by year